I

Icosavax, Inc.

53 employees

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
VLPs
Vaccine Development
Health Care
Respiratory syncytial virus
RSV
Infectious Disease
Vaccine
Vaccines
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$100M

from 18 investors over 18 rounds

I

Icosavax, Inc. raised $68M on May 22, 2023

Investors: Logos Global Management, LP, Vivo Capital and TCG X

I

Icosavax, Inc. raised $100M on April 7, 2021

Investors: Omega Funds, Sanofi Ventures, +ND Capital, Qiming Venture Partners USA, RA Capital Management, L.P., Viking Global Investors, Perceptive Advisors and Surveyor Capital

I

Icosavax, Inc. raised $10M on October 30, 2020

Investors: Bill & Melinda Gates Foundation

I

Icosavax, Inc. raised undisclosed on August 1, 2020

Investors: Good Ventures

I

Icosavax, Inc. raised $51M on October 3, 2019

Investors: Adams Street Partners, +ND Capital, Qiming Venture Partners USA and Sanofi Ventures

I

Icosavax, Inc. raised undisclosed on January 1, 2017

Investors: Sahsen Ventures, LLC

FAQ